Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Adrenal Disorders
•
Primary Hyperaldosteronism
Do you forgo adrenal imaging in a patient with primary hyperaldosteronism who has decided against surgery?
Do you have any concerns about missing an adrenal carcinoma if imaging is not pursued?
Answer from: at Academic Institution
Yes. It would be a waste of tome and money. Can go straight to using spironolactone or other mineralocorticoid blocker.
Sign in or Register to read more
29490
Related Questions
In patients with secondary adrenal insufficiency, when would you consider adding fludrocortisone to their steroid regimen?
Is adequate BP control sufficient enough when titrating spironolactone therapy for primary hyperaldosteronism treatment?
When starting stress dose steroids for patient with primary adrenal insufficiency, how do you decide whether to start hydrocortisone 100 mg every 8 hours versus 50 mg every 6 hours?
How often do you re-screen with autoantibody testing for type 1 diabetes if the initial test is negative in a patient with primary adrenal insufficiency?
What is the likelihood of recovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients who develop immunotherapy induced adrenal insufficiency?
Do patients with central adrenal insufficiency on maintenance hydrocortisone therapy require doubling of their corticosteroid during chemotherapy cycles?
For patients with adrenal insufficiency who are on hydrocortisone replacement, would you recommend stress doses to cover for minor procedures such as dental work or thyroid fine-needle aspiration biopsies?
How do you manage insomnia in a patient with Cushing syndrome, considering that elevated nighttime cortisol levels may contribute to their sleep disturbances?
Would you recommend testing for adrenal dysfunction in a euvolemic and hypertensive patient on anti-hypertensive therapy presenting with combined hyperkalemia and hyponatremia?
Are there any differences in specificity or sensitivity of the ACTH stimulation test when cosyntropin is administered intravenously versus intramuscularly?